Sei Investments CO Nymox Pharmaceutical Corp Transaction History

Sei Investments CO

  • $74.7 Billion
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2018

Nov 08, 2018
SELL
$2.46 - $3.7 $3,252 - $4,891
-1,322 Closed
0 $0
Q2 2018

Aug 03, 2018
BUY
$3.12 - $4.33 $4,124 - $5,724
1,322 New
1,322 $4,000

Others Institutions Holding NYMX

# of Institutions
6
Shares Held
150K
Call Options Held
0
Put Options Held
0
View Full List

About NYMOX PHARMACEUTICAL CORP

NYMX Quotes by TradingView
  • Ticker NYMX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 91,265,000
  • Market Cap $42.9M
  • Description
  • Nymox Pharmaceutical Corporation, a biopharmaceutical company, engages in the research and development of drugs for the aging population in Canada, the United States, Europe, and internationally. Its lead drug candidate is Fexapotide Triflutate (NX-1207), which has completed Phase III clinical trials for the treatment of benign prostatic hyperpl...
More about NYMX
Track This Portfolio

Track Sei Investments CO Portfolio

Follow Sei Investments CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sei Investments CO, based on Form 13F filings with the SEC.

News

Stay updated on Sei Investments CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email